A protocol is the most important document in a clinical study as it is the foundation for subsequent operational, regulatory, and marketing objectives for the development program. Developing a protocol […]
Over a three year period, Rho and Anthera Pharmaceuticals developed a collaborative partnership developing a product to treat Cystic Fibrosis. Some highlights of the partnership included: Expanding the scope of […]
Many trials, particularly those for treatments of psychiatric disorders or pain, involve the use of human raters. This article looks at how human raters can contribute to apparently high placebo […]
Diversity in clinical research is important for ethical and scientific reasons. When women and non-White populations are not represented in clinical research, this limits our understanding of the safety and efficacy of drugs to treat important health issues in these populations. Learn more about these findings in Yael Symes’ comprehensive blog.
